| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.0M | — | +82.7% |
| R&D Expense | $36.6M | — | +41.7% |
| SG&A Expense | $8.1M | — | +19.2% |
| Operating Income | -$43.6M | — | -36.2% |
| Income Tax | $0 | — | — |
| Net Income | -$40.6M | — | -48.8% |
| EPS (Basic) | -$0.75 | — | -47.1% |
| EPS (Diluted) | -$0.75 | — | -47.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $96.7M | -4.8% | +35.6% |
| Short-term Investments | $197.9M | -17.5% | -45.1% |
| Accounts Receivable | $1.0M | +54.8% | +82.7% |
| Current Assets | $316.3M | -10.1% | -30.3% |
| Total Assets | $318.1M | -10.1% | -30.3% |
| Current Liabilities | $13.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$47.9M | — | -16.2% |
| Investing Cash Flow | $42.4M | — | +119.9% |
| Financing Cash Flow | $598K | — | +1858.8% |
| +42.9% |
| Total Liabilities | $14.1M | +0.4% | +33.1% |
| Stockholders' Equity | $304.0M | -10.5% | -31.8% |